BIIB Stock Price Prediction 2026-2027
AI-powered forecast for Biogen Inc
Based on Wall Street consensus estimate - Medium Confidence
Current Price
$185.63
Price Targets for 2027
Bear Case
$188.25
+1.4%
Base Case
$191.03
+2.9%
Bull Case
$193.82
+4.4%
Prediction Tracking
Coming Soon for BIIB
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for BIIB
Key Factors Influencing BIIB Stock
Bullish Factors
- Revenue growth of 0.0% year-over-year
- Market position and competitive advantages
Risk Factors
- Market volatility and macroeconomic factors
- Competitive pressures in Drug Manufacturers - General
Prediction Methodology
These predictions are based on the Wall Street consensus price target of $191.03.
Bull and bear cases are calculated with a reasonable spread around the consensus based on historical volatility.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for BIIB
Frequently Asked Questions
What is BIIB stock price today?
BIIB (Biogen Inc) stock is trading at $185.63 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is BIIB stock going up or down today?
BIIB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy BIIB stock now?
The decision to buy BIIB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is BIIB a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for BIIB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is BIIB stock overvalued or undervalued?
BIIB currently trades at a P/E ratio of 17.09 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if BIIB is fairly priced.
What is BIIB's P/E ratio?
BIIB has a price-to-earnings (P/E) ratio of 17.09, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is BIIB's market cap?
BIIB (Biogen Inc) has a market capitalization of $27.52 billion, making it a mid-cap stock.
What is BIIB's price to book ratio?
BIIB trades at a price-to-book (P/B) ratio of 1.51, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Does BIIB pay dividends?
BIIB does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.
What is BIIB's dividend yield?
BIIB does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.
Is BIIB stock a good long-term investment?
BIIB's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is BIIB's revenue growth rate?
BIIB has shown revenue growth of 0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.
Is BIIB profitable?
Yes, BIIB is profitable with a profit margin of 0.2%. This indicates the company generates 0.2 cents of profit for every dollar of revenue.
What are the risks of investing in BIIB?
Key risks for BIIB include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does BIIB compare to its competitors?
Compare BIIB to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize BIIB's performance and positioning.
What is BIIB's stock price target for 2026?
Our AI model provides price targets for BIIB based on fundamental analysis: Bull case $241.32 (+30%), Base case $213.47 (+15%), Bear case $167.07 (-10%). Visit our prediction page for detailed forecasts.
What do analysts say about BIIB?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for BIIB. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is BIIB's next earnings report?
BIIB reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.